AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $561 | -45.6% | 133 | -60.1% | 0.00% | – |
| Q2 2023 | $1,032 | +271.2% | 333 | +66.5% | 0.00% | – |
| Q1 2023 | $278 | -30.2% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $398 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +96.1% | 0.00% | – |
| Q3 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 102 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 102 | -68.2% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 321 | +92.2% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 167 | +63.7% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -66.7% | 102 | -70.8% | 0.00% | – |
| Q2 2018 | $6,000 | – | 349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $103,087,000 | 5.89% |
| Eversept Partners, LP | 6,440,572 | $30,850,340 | 1.97% |
| TPG GP A, LLC | 16,213,367 | $77,662,000 | 0.78% |
| Signature Wealth Management Partners, LLC | 87,666 | $420,000 | 0.36% |
| Hedges Asset Management LLC | 75,000 | $359,000 | 0.28% |
| Hillsdale Investment Management Inc. | 869,916 | $4,167,000 | 0.28% |
| Tranquilli Financial Advisor LLC | 71,414 | $342,000 | 0.24% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $862,000 | 0.19% |
| GLOBEFLEX CAPITAL L P | 297,414 | $1,424,000 | 0.15% |
| XTX Topco Ltd | 23,742 | $114,000 | 0.06% |